Skin Denervation in Systemic Lupus Erythematosus
NCT00155532 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2005-09-12
Summary
To address the issues of skin denervation and its clinical and pathological correlations in systemic lupus erythematosus
Conditions
Interventions
- PROCEDURE
-
3 mm-punch biopsies of the skin
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Sung-Tsang Hsieh, MD, PhD · Department of Neurology, National Taiwan University Hospital, 7 Chung-Shan S Rd., Taipei 100, Taiwan
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-04-30
- Completion
- 2004-03-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381 ·Status: UNKNOWN
-
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
NCT00667134 ·Status: COMPLETED
-
Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo
NCT05121532 ·Status: UNKNOWN ·Phase: NA
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226 ·Status: RECRUITING ·Phase: NA
-
Islide-Establishing a Clinical Dermatopathology Online Discourse System
NCT01280435 ·Status: COMPLETED
-
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
NCT03211325 ·Status: COMPLETED ·Phase: NA
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
NCT01276314 ·Status: COMPLETED ·Phase: NA
-
Pilot Tape Harvesting Study
NCT02125695 ·Status: COMPLETED
-
Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers
NCT03406988 ·Status: UNKNOWN ·Phase: NA
-
Thymic Stromal Lymphopoietin (TSLP) in Vitiligo
NCT03367273 ·Status: COMPLETED ·Phase: NA
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
IL35 Level in Vitiligo
NCT05980390 ·Status: UNKNOWN
-
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
NCT02212249 ·Status: COMPLETED ·Phase: NA
-
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
NCT05990309 ·Status: UNKNOWN ·Phase: NA
-
Dermoscopy in Nails
NCT06696612 ·Status: NOT_YET_RECRUITING
-
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 ·Status: RECRUITING
-
Dermoscopy in Primary Raynaud's Phenomenon
NCT04644523 ·Status: COMPLETED
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease
NCT06399822 ·Status: RECRUITING ·Phase: NA